US Broker Ratings

SS Innovations International (SSII) Stock Analysis: Exploring Revenue Growth and Strategic Positioning in the Booming Medical Devices Sector

SS Innovations International Inc. (SSII), a formidable player in the healthcare sector, specifically within the medical devices industry, is making waves from its base in Gurugram, India. With a market..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Navigating the Future of Biotech with a $3.59 Billion Market Cap

Ascentage Pharma Group International (AAPG), a prominent Chinese biotechnology company, is making significant strides in the healthcare sector with its innovative therapies for cancer and chronic diseases. As a clinical-stage..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 37% Potential Upside Amidst Biotech Innovations

As a prominent player in the biotechnology sector, ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) has consistently demonstrated its commitment to advancing treatments for central nervous system (CNS) disorders and rare diseases...

Addus HomeCare Corporation (ADUS): Investor Outlook with a Promising 20.48% Upside

Addus HomeCare Corporation (NASDAQ: ADUS) is catching the attention of investors in the healthcare sector with its robust growth prospects and significant potential upside. Serving the United States as a..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: A Deep Dive into Potential 32.55% Upside for Investors

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector specializing in medical instruments and supplies, presents a compelling investment narrative with potential upside, reflected by a 32.55%..

Haemonetics Corporation (HAE) Stock Analysis: Navigating a 63.42% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector might find Haemonetics Corporation (NYSE: HAE) an intriguing prospect, given its substantial potential upside. With a market capitalization of $2.32 billion, Haemonetics operates..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Unpacking the 40% Potential Upside in Biotech

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) has been capturing attention in the biotechnology sector, with an impressive 40.68% potential upside according to analyst consensus. This Canadian company, headquartered in Burnaby, is..

Belite Bio, Inc (BLTE) Investor Outlook: Exploring a 27.74% Potential Upside in Biotech

Belite Bio, Inc (NASDAQ: BLTE), a promising player in the biotechnology sector, is capturing the attention of investors with its innovative approach to tackling retinal degenerative eye diseases. Based in..

Alvotech (ALVO) Stock Analysis: Unveiling a 108% Potential Upside in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a prominent player in the healthcare sector focusing on biosimilar medicines, presents a compelling investment narrative with a remarkable potential upside of 108.33%. Founded in Luxembourg in..

Galapagos NV (GLPG) Stock Report: Navigating a Challenging Biotech Landscape with -25.33% Potential Downside

Galapagos NV (NASDAQ: GLPG), a prominent biotechnology firm based in Belgium, is making waves in the healthcare sector with its innovative focus on oncology and immunology. Despite its cutting-edge research..

Ligand Pharmaceuticals (LGND) Stock Report: Analyst Consensus and Growth Potential Amidst Biopharmaceutical Innovations

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is making waves in the healthcare sector with its innovative biopharmaceutical portfolio. With a market capitalization of $3.38 billion, the biotechnology company is strategically positioned..

Merus N.V. (MRUS) Stock Analysis: Investor Outlook on a Promising Biotech Innovator

Merus N.V. (NASDAQ: MRUS) is drawing significant attention in the biotechnology sector, marking its presence with a notable market cap of $7.1 billion. As a clinical-stage immuno-oncology company based in..

Enovis Corporation (ENOV) Stock Analysis: Unlocking a 64.57% Potential Upside in the Medical Devices Sector

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, has caught the eye of many investors with its robust potential for growth. With a market capitalization of $1.73..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unpacking a 257.59% Potential Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX) is making waves in the biotechnology sector, driven by an impressive 257.59% potential upside according to analyst ratings. As a clinical-stage biopharmaceutical company, Viking Therapeutics..

Twist Bioscience Corporation (TWST): Investor Outlook Reveals 56% Upside Potential

Twist Bioscience Corporation (NASDAQ: TWST), a leader in the synthetic DNA sector, has been capturing attention with its innovative contributions to healthcare and diagnostics. Based in South San Francisco, California,..

Clover Health Investments (CLOV): Analyst Ratings Suggest 16.99% Upside Potential for This Healthcare Innovator

Clover Health Investments, Corp (CLOV) is at the forefront of transforming healthcare delivery in the United States. With a market capitalization of $1.64 billion, this Delaware-based company specializes in providing..

Surgery Partners, Inc. (SGRY) Stock Analysis: 40% Potential Upside Draws Investor Attention

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector, operates an extensive network of surgical facilities and ancillary services across the United States. Headquartered in Brentwood, Tennessee,..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: Potential 24.61% Upside as Biotech Innovator Advances

Scholar Rock Holding Corporation (NASDAQ: SRRK), a promising player in the biotechnology sector, is drawing significant attention from investors due to its innovative approach to treating serious diseases through protein..

CG Oncology, Inc. (CGON) Growth Potential: A Biotech Innovator with 63% Upside

CG Oncology, Inc. (NASDAQ: CGON) is capturing the interest of savvy investors with a promising outlook in the dynamic biotechnology sector. Specializing in bladder cancer therapeutics, CGON has carved a..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Biotech Gem With 75% Upside Potential

Catalyst Pharmaceuticals, Inc. (CPRX), a key player in the biotechnology sector, is making waves with its promising outlook and robust financial performance. Based in Coral Gables, Florida, and with a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds